Ophthalmic drug delivery: development and regulatory considerations.
Novack
G D
GD
PharmaLogic Development, Inc., San Rafael, California, USA. gary_novack@pharmalogic.com
D003261:Contact Lenses; D016503:Drug Delivery Systems; D004343:Drug Implants / Q000627:therapeutic use; D004335:Drug and Narcotic Control; D005128:Eye Diseases / Q000188:drug therapy*; D006801:Humans; D007478:Iontophoresis / Q000379:methods; D009883:Ophthalmic Solutions / Q000627:therapeutic use
D004343:Drug Implants; D009883:Ophthalmic Solutions